Furukawa O, Nishiwaki H, Takeuchi K, Okabe S
Jpn J Pharmacol. 1987 Apr;43(4):449-53. doi: 10.1254/jjp.43.449.
A single injection (s.c.) of prostaglandin biosynthesis inhibitors such as indomethacin (5 mg/kg), aspirin (200 mg/kg) and quinacrine (100 mg/kg) or a Na+.K+ ATPase inhibitor such as ouabain (10 mg/kg) significantly reduced the adaptive increase of HCO3- output caused by acid in the duodenum of anesthetized rats. These agents had no effect on basal duodenal HCO3- secretion and histamine-stimulated gastric acid secretion. Either of these agents, when given alone, had no effect on the duodenal mucosa of conscious rats, but produced damage in the proximal duodenum within 8 hr when given together with histamine (40 mg/kg X 3, s.c., every 2.5 hr). A significant relationship was found between the degrees of inhibition of acid-induced HCO3- output and the severity of duodenal lesions induced by these drugs (r = 0.8620, P less than 0.01). These results suggest that an impairment of the mechanisms related to acid-induced HCO3- secretion may be particularly relevant to the pathogenesis of duodenal lesions.
单次皮下注射前列腺素生物合成抑制剂,如吲哚美辛(5毫克/千克)、阿司匹林(200毫克/千克)和奎纳克林(100毫克/千克),或钠钾ATP酶抑制剂,如哇巴因(10毫克/千克),可显著降低麻醉大鼠十二指肠中酸引起的HCO3-分泌适应性增加。这些药物对基础十二指肠HCO3-分泌和组胺刺激的胃酸分泌无影响。这些药物单独使用时,对清醒大鼠的十二指肠黏膜无影响,但与组胺(40毫克/千克×3,皮下注射,每2.5小时一次)一起给药时,8小时内在十二指肠近端产生损伤。发现酸诱导的HCO3-分泌抑制程度与这些药物诱导的十二指肠病变严重程度之间存在显著相关性(r = 0.8620,P < 0.01)。这些结果表明,与酸诱导的HCO3-分泌相关的机制受损可能与十二指肠病变的发病机制特别相关。